On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are New York Genome Center, Inc's own share of each project, not the project's full budget.
- Horizon Europe€0 · 1 project
- Horizon 2020€0 · 1 project
Projects
2 EU-funded projects, newest first. Each links to the official record.
- T-REaCTAssociated partner
Evolution of T cell reactivity against somatic mutations across human colon cancer stages with single-cell genomics and synthetic T cell specificity screening
Horizon Europe · 2026–2028 · Project on CORDIS ↗
- IMAGENEPartner
Characterizing Function Genetic Variants Linking Immunity and Psychiatric Disorders
Horizon 2020 · 2017–2020 · Project on CORDIS ↗
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
Fields it works in
Research fields recorded on its Horizon projects.
- evolutionary biology
- genomes
- immunology
- immunotherapy
- medical genetics
- mutation
- oncology
- pathology
- schizophrenia
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.